skip to primary navigationskip to content
 

Research News

Cost and scale of field trials for bovine TB vaccine may make them unfeasible

Cost and scale of field trials for bovine TB vaccine may make them unfeasible

Field trials for a vaccine to protect cattle against bovine tuberculosis (bovine TB) would need to involve 500 herds – potentially as many as 75,000-100,000 cattle – to demonstrate cost effectiveness for farmers, concludes a study published today in the journal eLife.

Cost and scale of field trials for bovine TB vaccine may make them unfeasible - Read More…

Human anti-cancer drugs could help treat transmissible cancers in Tasmanian devils

Transmissible cancers are incredibly rare in nature, yet have arisen in Tasmanian devils on at least two separate occasions. New research from the University of Cambridge identifies key anti-cancer drugs which could be trialled as a treatment for these diseases, which are threatening Tasmanian devils with extinction.

Human anti-cancer drugs could help treat transmissible cancers in Tasmanian devils - Read More…

2017

News stories from 2017: brachycephalic dogs, agricultural yields, antimicrobial resistance and HIV vaccine development

2017 - Read More…

2016

News stories from 2016: the contagious cancer that conquered the world; second contagious form of cancer found in Tasmanian devils; saving inbred, short-faced dogs such as pugs and bulldogs from poor health; new blood test for vCJD; predicting outbreaks of Ebola and Lassa fever

2016 - Read More…

2015

News stories for 2015: damaged nerve cells communicate with stem cells; MRSA in supermarket sausages and minced pork; the bacteria lurking in your chicken; virus evolution and human behaviour shape global patterns of flu movement; changing rearing practices and pig-borne disease; minimising ‘false positives’ key to vaccinating against bovine TB; superspreaders and the role of human transmission in Lassa infection

2015 - Read More…